EntryPoint Capital’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,503	Closed	-$87.6K	–	1011
2024 Q2	$87.6K	Sell	8,503 -10,877	-56%	-$112K	0.13%	364
2024 Q1	$206K	Buy	+19,380	New	+$206K	0.18%	109